nifedipine has been researched along with Idiopathic Parkinson Disease in 3 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, XJ | 1 |
Xu, JX | 1 |
Hashimoto, T | 1 |
Yabe-Nishimura, C | 1 |
Nishino, N | 1 |
Noguchi-Kuno, SA | 1 |
Sugiyama, T | 1 |
Tanaka, C | 1 |
3 other studies available for nifedipine and Idiopathic Parkinson Disease
Article | Year |
---|---|
Possible involvement of Ca2+ signaling in rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells.
Topics: Apoptosis; Calcium; Calcium Channel Blockers; Caspases; Cell Cycle; Cell Line, Tumor; Chelating Agen | 2005 |
Oxidative metabolite of dopamine, 3,4-dihydroxyphenylacetaldehyde, induces dopamine release from PC12 cells by a Ca2+-independent mechanism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Calcium; Calcium Channel Blockers; Dopamine; L-Lactate Dehy | 2002 |
[3H]Nitrendipine binding sites are decreased in the substantia nigra and striatum of the brain from patients with Parkinson's disease.
Topics: Aged; Binding Sites; Caudate Nucleus; Corpus Striatum; Female; Globus Pallidus; Humans; Male; Nifedi | 1986 |